ENTITY

IVERIC bio (ISEE US)

4

Analysis

Health Care • United States

IVERIC bio, Inc. operates as a biopharmaceutical company. The Company develops treatments for patients with orphan inherited retinal diseases with significant unmet medical needs. IVERIC bio serves customers in the United States.

more

Refresh

Exchange Announcement • 21 Jul 2023 16:30

US SEC Form 15-12G for IVERIC bio, Inc.

Exchange Announcement • 13 Jul 2023 22:02

Statement of changes in beneficial ownership of securities - general instructions (PDF)

Exchange Announcement • 13 Jul 2023 22:01

Statement of changes in beneficial ownership of securities - general instructions (PDF)

Exchange Announcement • 13 Jul 2023 22:00

Statement of changes in beneficial ownership of securities - general instructions (PDF)

Exchange Announcement • 13 Jul 2023 22:00

Statement of changes in beneficial ownership of securities - general instructions (PDF)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5

x